FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to new saccharides, and can be applied in medical practice.
EFFECT: invention discloses a modified O-polysaccharide capable of stimulating an immune response in a mammal against pathogenic E. coli serotypes.
25 cl, 25 dwg, 21 tbl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ESCHERICHIA COLI COMPOSITIONS AND METHODS BASED THEREON | 2021 |
|
RU2821929C1 |
| FIMH ESCHERICHIA COLI MUTANTS AND USE THEREOF | 2021 |
|
RU2831010C1 |
| PURIFICATION OF SACCHARIDES | 2021 |
|
RU2816593C1 |
| INCREASE IN IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES | 2018 |
|
RU2774891C2 |
| METHOD OF INCREASING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN | 2021 |
|
RU2830627C1 |
| NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS FOR USING THEM | 2017 |
|
RU2739504C2 |
| COMPOSITIONS OF IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATES AND USE THEREOF | 2015 |
|
RU2720295C2 |
| IGG4 Fc FRAGMENT CONTAINING A MODIFIED HINGE REGION | 2014 |
|
RU2800558C1 |
| SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY GLYCOENGINEERING | 2014 |
|
RU2831409C2 |
| IMMUNOGENIC FUSED PROTEIN | 2016 |
|
RU2757426C2 |
